Insulin glargine and lixisenatide Subcutaneous and Angioedema
Result of checking the interaction of drug Insulin glargine and lixisenatide Subcutaneous and disease Angioedema for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:The use of lixisenatide may result in cross-sensitivity in patients with a history of anaphylaxis reaction or angioedema to another GLP-1 receptor agonist. These patients should be informed of the risk of anaphylaxis when using lixisenatide. Close monitoring is recommended when prescribing lixisenatide to these patients.
Generic Name: insulin glargine / lixisenatide
Brand Name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Insulin glargine and lixisenatide Subcutaneous - obrzęk naczynioruchowy 
Insulin glargine and lixisenatide Subcutaneous - angioedema 
Insulin glargine and lixisenatide Subcutaneous - angioedema 
Insulin glargine and lixisenatide Subcutaneous - angioedema 
Insulin glargine and lixisenatide Subcutaneous - angioedema 
Insulin glargine and lixisenatide Subcutaneous - angioedème 
Insulin glargine and lixisenatide Subcutaneous - Angioödem 
Insulin glargine and lixisenatide Subcutaneous - angioedema 
Insulin glargine and lixisenatide Subcutaneous - ангионевротический отек 
Insulin glargine and lixisenatide Subcutaneous - anjiyoödem 
Insulin glargine and lixisenatide Subcutaneous - وذمة وعائية 
Insulin glargine and lixisenatide Subcutaneous - 血管性水肿